| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6239ff6fe13e938cdf6854d9e1d1dee7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 |
| filingDate |
2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b37616033cba84db7c2f634a2bfc98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0d49dc64be5a82ebbac771e62f11a37 |
| publicationDate |
2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2954896-A1 |
| titleOfInvention |
Small molecule inhibitors of the E3 Ligase Skp2 in depression and other diseases |
| abstract |
The present invention relates to Skp2 inhibitors for the use in the therapeutic activation of autophagy and especially for use as an antidepressant. Furthermore the present invention refers to a method of determining if a subject suffering from depression responds to an antidepressant and to a method for screening for novel compounds for the therapeutic activation of autophagy which is suitable for different diseases, such as depression. |
| priorityDate |
2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |